CRB Health Tech SGEIC

CRB Health Tech invests in health technologies at various stages, including seed and Series A. Their investment strategy emphasizes the convergence of digital technologies and healthcare, targeting opportunities that enhance healthcare access, efficiency, and patient empowerment. The firm primarily operates in Spain and across Europe, with ticket sizes ranging from €500,000 to €1.5 million, and up to €4-5 million per company.

Key sectors of interest include healthcare, biotech, digital health, and medical devices. CRB Health Tech seeks to partner with founders who demonstrate a strong vision for improving health outcomes through innovative solutions. The firm values companies that can effectively integrate digital technologies into healthcare practices, thereby enhancing patient engagement and operational efficiency.

CRB Health Tech's portfolio consists of 20 companies, showcasing a diverse range of health technologies. Notable companies include:

• Health in Code: Market stage diagnostic drug for hypolactasia.
• TCD Pharma: First-in-class small molecule for the targeted treatment of solid tumors.
• Green Molecular: Pterostilbene formulations for dermatology and oncology.
• OWL Metabolomics: Metabolomic platform with the first marketed non-invasive diagnostic LDT for NASH.
• Thryve: SaaS platform for 24/7 health data access from consumer wearables.
• Carol: Virtual primary care for employees.
• Biocross: Blood-based biomarkers for early diagnosis of Alzheimer Disease, including the APOE4 test.
• nLife Therapeutics: Metabolomic platform with the first marketed non-invasive diagnostic LDT for NASH.
• Raman Health Technologies: Development of a diagnostic platform based on Raman and infrared spectroscopy technology.
• Iden Biotechnology: Crop improvement through genetic and biotechnology.
• Aglaris Cell: Novel bioreactor technology for automated mesenchymal and T-cell cultures.
• Oncovision: Dedicated PET and molecular imaging for breast cancer, neurodegeneration, and surgery.
• AMADIX: Early cancer detection blood test.
• PreveCol: Detection of colorectal cancer and advanced adenomas.
• NUUBO: Design, manufacturing, and commercialization of wearable textile medical technologies for cardiac prevention, diagnosis, and rehabilitation.
• Mecwins: Development of an ultra-sensitive diagnostic platform based on nanomechanical biosensors and photoluminescence.
• Livo: SaaS platform to optimize attraction and retention of healthcare professionals.
• Prosoma: Personalized mental health support for cancer patients.
• Toothfairy: Teledentistry app offering remote dental care and at-home treatment solutions.
• Zoundream: AI-based analysis of baby cries to detect needs and early health conditions.
• Circle Health: Personalized healthcare for individuals seeking clarity and guidance beyond short appointments.

Enrique Castellón - Partner: Enrique has extensive experience in venture capital and health technologies, having led multiple successful investments in the sector.

Ángel Santos - Partner: Ángel specializes in biotech investments and has a strong background in life sciences, contributing to the firm's strategic direction.

Joaquín Velasco - Partner: Joaquín brings expertise in digital health and has been instrumental in identifying emerging trends in the healthcare market.

Manuel Castellón - Partner: Manuel focuses on medical devices and has a track record of successful exits in the health tech space.

Alejo Costa Rialta - Partner: Alejo has a background in finance and operations, providing valuable insights into the business aspects of portfolio companies.

Ignasi Heras - Partner: Ignasi specializes in early-stage investments and has a keen eye for innovative health solutions.

Tim Juergens - Partner: Tim has a strong background in healthcare consulting and supports portfolio companies in scaling their operations.

Antonio Serrano - Strategic Advisor: Antonio provides strategic insights and guidance to the firm, leveraging his extensive network in the healthcare industry.

María Jaraiz - Partner: María focuses on investment analysis and has a strong background in health economics.

Isabel Santamaria - Head of Financial & Admin: Isabel oversees the financial operations of the firm, ensuring compliance and efficiency.

Beatriz Plaza - Investment Associate: Beatriz supports the investment team in due diligence and portfolio management.

Brigida Escudero - Administrative Support: Brigida provides administrative assistance to the team, facilitating smooth operations.

Samantha López-Mochales - Investment Analyst: Samantha conducts market research and analysis to support investment decisions.

To pitch CRB Health Tech, startups should use the preferred channel of their website or email. A well-structured pitch deck should include an overview of the business model, market opportunity, competitive landscape, and team qualifications. Founders are encouraged to provide data supporting their claims and demonstrate traction.

Response times can vary, but startups can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.

In recent activity, CRB Health Tech has completed a notable divestment from Health in Code, marking the conclusion of a successful value creation cycle in health innovation. This exit highlights the firm's ability to identify and nurture promising health tech companies.

Additionally, CRB Health Tech continues to manage its portfolio actively, focusing on enhancing the growth and market reach of its investments. The firm remains committed to supporting health technology innovations that improve patient outcomes.